Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
R-Crio is a Brazilian biotechnology company specializing in the isolation and cryopreservation of mesenchymal stem cells, primarily derived from dental pulp. The company offers a unique "bio-insurance" service, enabling families to store healthy stem cells from deciduous or permanent teeth for potential future use in regenerative medicine. Operating out of a specialized laboratory in Campinas, R-Crio utilizes proprietary protocols to ensure high cell viability and quality during the processing and long-term storage phases. Their focus is on providing a non-invasive and ethically sound source of stem cells that can potentially treat various conditions involving bone, muscle, and nerve tissue. The company also engages in research and development to expand the clinical applications of stored cells and maintains a large network of accredited dental professionals for cell collection.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on R-Crio Criogenia.